Clinical trials
Phase 2 Amyotrophic Lateral Sclerosis trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cytokinetics | 2 |
| Novartis Pharmaceuticals | 2 |
| University of Calgary | 2 |
| AL-S Pharma | 1 |
| Anelixis Therapeutics, LLC | 1 |
| Annexon, Inc. | 1 |
| Corcept Therapeutics | 1 |
| CytRx | 1 |
| GlaxoSmithKline | 1 |
| Neuraltus Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyotrophic Lateral Sclerosis | 21 |
| Motor Neuron Disease | 4 |
| Central Nervous System Diseases | 1 |
| Inflammation | 1 |
| Nervous System Diseases | 1 |
| Neurodegenerative Diseases | 1 |
| Neuromuscular Diseases | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.